Showing results 5 to 9 of 9
HS-133, a novel fluorescent phosphatidylinositol 3-kinase inhibitor as a potential imaging and anticancer agent for targeted therapy Lee, Ju-Hee; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Yun, Sun-Mi; Ahn, Sung-Hoon; Lee, Kyeong-Ryoon; et al, ONCOTARGET, v.5, no.20, pp.10180 - 10197, 2014-10 |
Induction of apoptosis and suppression of angiogenesis of hepatocellular carcinoma by HS-159, a novel phosphatidylinositol 3-kinase inhibitor Yun, Sun-Mi; Lee, Ju-Hee; Jung, Kyung Hee; Lee, Hyunseung; Lee, Soyoung; Hong, Sungwoo; Hong, Soon-Sun, INTERNATIONAL JOURNAL OF ONCOLOGY, v.43, no.1, pp.201 - 209, 2013-07 |
Structure-based de novo design and synthesis of aminothiazole-based p38 MAP kinase inhibitors Park, Hwangseo; Lee, Soyoung; Hong, Sungwoo, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.25, no.18, pp.3784 - 3787, 2015-09 |
Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors Choi, Hwanho; Park, Ho Jeong; Shin, Jong Chul; Ko, Hyun Sun; Lee, Jung Kyun; Lee, Soyoung; Park, Hwangseo; et al, BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.22, no.6, pp.2195 - 2199, 2012-03 |
Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor Jung, Kyung Hee; Zheng, Hong-Mei; Jeong, Yujeong; Choi, Myung-Joo; Lee, Hyunseung; Hong, Sang-Won; Lee, Hee-Seung; et al, CANCER LETTERS, v.328, no.1, pp.176 - 187, 2013-01 |
Discover